For millions of people suffering from diabetes, new technology enabled by promises to make management much easier. Medtronic’s Guardian Connect system promises to alert users 10 to 60 minutes before they hit high or low blood sugar level thresholds, thanks to IBM Watson , “the same supercomputer technology that can predict global weather patterns.”
copyright by slate.com
Startup Beta Bionics goes even further: In May, it received Food and Drug Administration approval to start clinical trials on what it calls a “bionic pancreas system” powered by , capable of “automatically and autonomously managing blood sugar levels 24/7.”
An artificial pancreas powered by represents a huge step forward for the treatment of diabetes—but getting it right will be hard. Artificial intelligence (also known in various iterations as and ) promises to automatically learn from patterns in medical data to help us do everything from managing diabetes to finding tumors in an MRI to predicting how long patients will live . But the
Diabetes devices provide an example in microcosm of broader issues with
To understand the challenge in diabetes, it helps to know the technological baseline. The traditional way to administer insulin to patients with Type 1 diabetes (where the pancreas doesn’t make insulin at all) or Type 2 diabetes (where the body becomes resistant to insulin) that can’t be managed with oral medication is through finger-sticks and injections. Patients check their blood sugar by pricking the tip of a finger and using a small test strip to measure the level of glucose in the blood. Patients also inject insulin manually, using a syringe, based on blood sugar readings and knowing when they are going to need extra insulin (typically around meals). […]
0 Comments